Home/Filings/4/0001104659-24-025520
4//SEC Filing

Rothbaum Wayne P. 4

Accession 0001104659-24-025520

CIK 0001425205other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:11 PM ET

Size

5.9 KB

Accession

0001104659-24-025520

Insider Transaction Report

Form 4
Period: 2024-02-20
Transactions
  • Purchase

    Common Stock

    2024-02-20$9.15/sh+5,000,000$45,750,00028,067,333 total(indirect: By LLC)
Footnotes (3)
  • [F1]Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer.
  • [F2]The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC.
  • [F3]Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.

Issuer

IOVANCE BIOTHERAPEUTICS, INC.

CIK 0001425205

Entity typeother

Related Parties

1
  • filerCIK 0001423102

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:11 PM ET
Size
5.9 KB